Delivery Order SPE2DB20D3101-SPE2DB23FRUN1

Award Date 8/10/23
Potential Completion Date 8/11/23
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,412.35 firm fixed-price delivery order is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,472.91 firm fixed-price delivery order is for the supply of 4 mg naloxone hydrochloride nasal spray, which is a critical medication used to treat opioid overdose. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,903.72 firm fixed-price delivery order is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,188.48 firm-fixed-price delivery order is for the supply of 4 mg Naloxone HCL nasal spray, a critical medication used to reverse opioid overdoses. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,172.16 firm fixed-price delivery order is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. This award is made under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,135.04 firm fixed-price delivery order is for the procurement of 4,559,306 units of 4 mg naloxone hydrochloride nasal spray, a critical medication used to treat opioid overdoses. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,364.04 firm fixed-price award is for the supply of 4,567,104,095 units of 4 mg naloxone hydrochloride nasal spray, which is a critical medication used to reverse opioid overdoses. The award is not designated under any set-aside program, indicating open competition. This delivery order is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,559.72 firm fixed-price delivery order is for the supply of Naloxone HCL 4 mg nasal spray, a critical medication used to reverse opioid overdoses. The contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,275.16 firm fixed-price delivery order is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. The contract has an ultimate completion date of June 7, 2023 and was awarded on June 6, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,355 firm fixed-price delivery order is for the supply of 4 mg naloxone hydrochloride nasal spray, which is used to treat opioid overdose. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRUN1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,716.44 firm-fixed-price delivery order is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to reverse opioid overdoses.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses a broad array of essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas.

The contract does not have a set-aside designation, indicating open competition. No subcontractors were mentioned in the provided information.

Generated 2/27/25, 11:10 AM